Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020.

ABSTRACT:

Importance

Despite controversy surrounding the 340B program, no study has analyzed trends in the proportion of Medicare Part D pharmacy claims eligible for 340B discounts.

Objective

To describe trends in the proportion of Medicare Part D claims that are prescribed by 340B-affiliated clinicians and filled in 340B pharmacies.

Design and setting

This longitudinal, retrospective cohort study included 2013 to 2020 claims data from a 5% random sample of Medicare Part D beneficiaries from the Centers for Medicare & Medicaid Services and 6292 nine-digit national drug codes that were used by at least 1000 Part D beneficiaries in a given year. Data analysis was completed from November 2022 to April 2023.

Main outcomes and measures

For each drug and year, there were 3 out

SUBMITTER: Dickson S 

PROVIDER: S-EPMC10656642 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature